$RVYL
RYVYL Inc. Stock $rvyl

$rvyl Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000118518522000938 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$10.63M	$6.966M	$4.896M
YoY Change	32.12%	9.19%	3.06%
Cost Of Revenue	$4.270M	$4.143M	$2.564M
YoY Change	76.37%	213.03%	61.25%
Gross Profit	$6.360M	$2.823M	$2.332M
YoY Change	13.08%	-44.17%	-26.21%
Gross Profit Margin	59.83%	40.52%	47.63%
Selling, General & Admin	$5.680M	$7.555M	$6.114M
YoY Change	-17.41%	76.98%	-48.45%
% of Gross Profit	89.31%	267.66%	262.23%
Research & Development	$1.442M	$1.920M	$1.938M
YoY Change	38.21%	137.56%	198.17%
% of Gross Profit	22.67%	68.02%	83.12%
Depreciation & Amortization	$35.22K	$34.34K	$454.3K
YoY Change	-92.42%	368.55%	4443.4%
% of Gross Profit	0.55%	1.22%	19.49%
Operating Expenses	$9.423M	$11.60M	$8.507M
YoY Change	12.47%	127.87%	-32.11%
Operating Profit	-$3.063M	-$8.779M	-$6.175M
YoY Change	11.23%	24552.68%	-34.1%
Interest Expense	$907.0K	$1.780M	-$15.11M
YoY Change	-19234.22%		320.9%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$49.32K
YoY Change	-100.0%		-593.2%
Pretax Income	-$15.14M	$10.33M	-$21.24M
YoY Change	441.35%	-26218.91%	59.31%
Income Tax	$34.79K	-$77.44K	$79.90K
% Of Pretax Income		-0.75%
Net Earnings	-$15.17M	$10.41M	-$21.32M
YoY Change	150.76%	-26414.67%	59.91%
Net Earnings / Revenue	-142.72%	149.45%	-435.42%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.22	$242.2K	-$506.2K
COMMON SHARES
Basic Shares Outstanding	44.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.00M	$29.10M	$27.59M
YoY Change	-62.97%	-2.34%	-22.71%
Cash & Equivalents	$11.02M	$29.10M	$27.59M
Short-Term Investments
Other Short-Term Assets	$855.1K	$1.144M	$35.26M
YoY Change	227.69%	-43.58%	1339.33%
Inventory	$273.7K	$259.9K	$217.1K
Prepaid Expenses
Receivables	$790.1K	$619.9K	$468.6K
Other Receivables	$22.20M	$20.55M	$20.81M
Total Short-Term Assets	$68.38M	$84.88M	$84.35M
YoY Change	30.05%	68.25%	59.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.702M	$1.715M	$3.070M
YoY Change	-25.97%	81.19%	1946.61%
Goodwill	$26.63M	$26.63M	$6.548M
YoY Change
Intangibles	$22.39M	$24.51M
YoY Change
Long-Term Investments	$1.500M
YoY Change
Other Assets	$186.0K	$186.0K	$172.4K
YoY Change	-6.02%	2.99%	115.44%
Total Long-Term Assets	$54.02M	$54.90M	$34.56M
YoY Change	226.6%	1387.74%	14925.08%
TOTAL ASSETS
Total Short-Term Assets	$68.38M	$84.88M	$84.35M
Total Long-Term Assets	$54.02M	$54.90M	$34.56M
Total Assets	$122.4M	$139.8M	$118.9M
YoY Change	77.08%	158.19%	124.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.70M	$34.82M	$6.460M
YoY Change	205.27%	622.91%	16.81%
Accrued Expenses	$600.0K	$2.445M	$2.325M
YoY Change	59.79%	466.75%	2483.66%
Deferred Revenue
YoY Change
Short-Term Debt	$12.87K	$0.00	$0.00
YoY Change	-95.34%	-100.0%	-100.0%
Long-Term Debt Due	$12.87K	$0.00
YoY Change
Total Short-Term Liabilities	$27.27M	$39.19M	$35.83M
YoY Change	133.66%	592.89%	498.16%
LONG-TERM LIABILITIES
Long-Term Debt	$637.0K	$649.9K	$58.83M
YoY Change	-1.26%	333.56%	39117.27%
Other Long-Term Liabilities	$1.100M	$1.233M	$891.7K
YoY Change	273.53%	206.88%
Total Long-Term Liabilities	$637.0K	$649.9K	$59.72M
YoY Change	-32.2%	17.81%	39711.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.27M	$39.19M	$35.83M
Total Long-Term Liabilities	$637.0K	$649.9K	$59.72M
Total Liabilities	$87.70M	$99.83M	$95.55M
YoY Change	595.37%	1508.16%	1456.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$64.25M	-$49.08M	-$80.18M
YoY Change	82.47%	69.76%	180.27%
Common Stock	$48.16K	$43.88K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$8.473M
YoY Change	-100.0%	-100.0%
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$34.71M	$39.95M	$23.36M
YoY Change
Total Liabilities & Shareholders Equity	$122.4M	$139.8M	$118.9M
YoY Change	77.08%	158.19%	124.23%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$15.17M	$10.41M	-$21.32M
YoY Change	150.76%	-26414.67%	59.91%
Depreciation, Depletion And Amortization	$35.22K	$34.34K	$454.3K
YoY Change	-92.42%	368.55%	4443.4%
Cash From Operating Activities	-$14.54M	$29.63M	-$7.857M
YoY Change	-1392.44%	-1330.45%	-30.22%
INVESTING ACTIVITIES
Capital Expenditures	-$150.0K	-$682.4K	-$66.09K
YoY Change	410.03%	1068.29%	560.9%
Acquisitions
YoY Change
Other Investing Activities	-$1.450M	$0.00	-$44.81M
YoY Change		-100.0%
Cash From Investing Activities	-$1.300M	-$682.4K	-$44.88M
YoY Change	4320.27%	-73.33%	448666.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	-9.232M
YoY Change	-100.0%	-100.0%	-120.46%
NET CHANGE
Cash From Operating Activities	-14.54M	29.63M	-7.857M
Cash From Investing Activities	-1.300M	-682.4K	-44.88M
Cash From Financing Activities	0.000	0.000	-9.232M
Net Change In Cash	-15.84M	28.95M	-61.97M
YoY Change	17598.32%	-590.95%	-283.0%
FREE CASH FLOW
Cash From Operating Activities	-$14.54M	$29.63M	-$7.857M
Capital Expenditures	-$150.0K	-$682.4K	-$66.09K
Free Cash Flow	-$14.39M	$30.31M	-$7.791M
YoY Change	-1346.52%	-1390.08%	-30.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	001-34294
CY2022Q2	us-gaap	Inventory Net InventoryNet	259924	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	286360	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	3904952	usd
	dei	Entity Registrant Name EntityRegistrantName	GREENBOX POS
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3962936
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3131 Camino Del Rio North, Suite 1400
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92108
	dei	City Area Code CityAreaCode	(619)
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3127	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Local Phone Number LocalPhoneNumber	631-8261
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	GBOX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44842023	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29098753	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89559695	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	26526234	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54795	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54795	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	619920	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	481668	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3127	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	3904952	usd
CY2022Q2	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	14270698	usd
CY2021Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	18941761	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14104587	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6420696	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	84880116	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	115690180	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1714914	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1674884	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186038	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	190636	usd
CY2022Q2	us-gaap	Goodwill Goodwill	26625946	usd
CY2021Q4	us-gaap	Goodwill Goodwill	6048034	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24505648	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7578935	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1868633	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1490159	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	54901179	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	16982648	usd
CY2022Q2	us-gaap	Assets Assets	139781295	usd
CY2021Q4	us-gaap	Assets Assets	132672828	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1347629	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	871037	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1869049	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	501167	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1717398	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1226287	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	33467867	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4997807	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	61006	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	18735000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	728076	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	495134	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	39191025	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26826432	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	649900	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	649900	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	30241836	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	41344822	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	58758165	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	58655178	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1232868	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1035895	usd
CY2022Q2	us-gaap	Liabilities Liabilities	99831958	usd
CY2021Q4	us-gaap	Liabilities Liabilities	87167405	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	82500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	82500000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44600527	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44600527	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43546647	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43546647	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	43884	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	42831	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	grbx	Common Stock Issuable Shares Issuable CommonStockIssuableSharesIssuable	754423	shares
CY2021Q4	grbx	Common Stock Issuable Shares Issuable CommonStockIssuableSharesIssuable	0	shares
CY2022Q2	grbx	Common Stock Issuable CommonStockIssuable	754	usd
CY2021Q4	grbx	Common Stock Issuable CommonStockIssuable	0	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89386501	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	88574469	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-397839	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49083963	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38178061	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	714831	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	0	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4933816	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	39949337	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45505423	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139781295	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132672828	usd
CY2022Q2	us-gaap	Revenues Revenues	6965578	usd
CY2021Q2	us-gaap	Revenues Revenues	6379179	usd
	us-gaap	Revenues Revenues	11861104	usd
	us-gaap	Revenues Revenues	11128620	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	4142878	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1323480	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6706708	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2917251	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2822700	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	5055699	usd
	us-gaap	Gross Profit GrossProfit	5154396	usd
	us-gaap	Gross Profit GrossProfit	8211369	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	526852	usd
CY2021Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	22605	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	667818	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	47330	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1919944	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	808210	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3858077	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1461591	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1353604	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	298030	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3145788	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	864225	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2712424	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1061929	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5095821	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1621130	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	1167798	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	867472	usd
	us-gaap	Professional Fees ProfessionalFees	2672359	usd
	us-gaap	Professional Fees ProfessionalFees	1325224	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1291887	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	166800	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2089500	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1715298	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1715298	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	79238	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	726933	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	205652	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10180758	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2126607	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14244	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2580948	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20253	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	11601765	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	5091310	usd
	us-gaap	Operating Expenses OperatingExpenses	20108561	usd
	us-gaap	Operating Expenses OperatingExpenses	17610011	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8779065	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-35611	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14954165	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9398642	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1866016	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3755501	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-594258	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5582164	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	11102986	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2993408	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	26373994	usd
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	18673994	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	0	usd
CY2021Q2	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	364124	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	185893	usd
CY2021Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3949	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	235209	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18560	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19111707	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3949	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4050716	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3970350	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10332642	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39560	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10903449	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13368992	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-77443	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2453	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	10410085	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-39560	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10905902	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13368992	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	10410085	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-39560	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10905902	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13368992	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-397839	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-397839	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10012246	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39560	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11303741	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13368992	usd
CY2022Q2	grbx	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0.24
CY2021Q2	grbx	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0
	grbx	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.26
	grbx	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.43
CY2022Q2	grbx	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	42977461	shares
CY2021Q2	grbx	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	31078605	shares
	grbx	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	42541262	shares
	grbx	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	31208102	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	23361142	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	79238	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1496711	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5000000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-397839	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	10410085	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	39949337	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45505423	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	205652	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1496711	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5215	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2110000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5000000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3236723	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	166800	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-397839	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10905902	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	39949337	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	46885338	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	727139	usd
CY2021Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	933343	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1291887	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-39560	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	47931461	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	385236	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3520000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3850000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10180964	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2250	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4194000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2089500	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	933343	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13368992	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	47931461	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10905902	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13368992	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2580948	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20253	usd
	grbx	Noncash Lease Expense NoncashLeaseExpense	-79034	usd
	grbx	Noncash Lease Expense NoncashLeaseExpense	1720	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	166800	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2089500	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-205652	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	14156166	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	11102986	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2993408	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18673994	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-48077	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-10180758	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	594258	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1715298	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5904437	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3094938	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13667974	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86952	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68411	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	661536	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	28810600	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44200398	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	18676860	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	138252	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	65444	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-26436	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1011321	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1958422	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-4671063	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	8455120	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-35348	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	99000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-239131	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2186733	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	67853	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	732221	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	491111	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	0	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	16000000	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45559088	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2568411	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	3236723	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	933343	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5215	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2250	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	6000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3520000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4194000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45805491	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9231508	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33018798	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	27964013	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-915910	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89559695	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1832735	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55624987	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29796748	usd
	us-gaap	Interest Paid InterestPaid	3127111	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	5000000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	3850000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	58050	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29098753	usd
	us-gaap	Basis For Attributing Revenues From External Customers To Individual Countries BasisForAttributingRevenuesFromExternalCustomersToIndividualCountries	revenues from three geographic areas, consisting of North America and Europe
CY2022Q2	us-gaap	Revenues Revenues	6965578	usd
CY2021Q2	us-gaap	Revenues Revenues	6379179	usd
	us-gaap	Revenues Revenues	11861104	usd
	us-gaap	Revenues Revenues	11128620	usd
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	26220562	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	9253819	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24505648	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with the GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.8663	pure
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89559695	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	26526234	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55624987	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89559695	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8431283	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	61006	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	18735000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1757516	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	149749	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	82632	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1714914	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	852348	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7578935	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2092267	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1674884	usd
CY2022Q2	us-gaap	Depreciation Depreciation	34340	usd
CY2021Q2	us-gaap	Depreciation Depreciation	7329	usd
	us-gaap	Depreciation Depreciation	67117	usd
	us-gaap	Depreciation Depreciation	13338	usd
	grbx	Covid19 Update Textblock COVID19UpdateTextblock	<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"> <tr> <td style="vertical-align:top;width:2.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>3. </b></p> </td> <td style="vertical-align:top;width:43.5%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COVID-19 UPDATE</b></p> </td> </tr> </table><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In December 2019, a novel strain of coronavirus (“COVID-19”) was identified and the disease has since spread across the world. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains, and created significant volatility and disruption in the financial and capital markets. The full extent to which the COVID-19 outbreak will impact the Company’s business, results of operations, financial condition and cash flows will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning COVID-19 and the actions to contain or treat its impact and the economic impact and the economic impact on local, regional, national and international markets. As the COVID-19 pandemic continues, the Company’s results of operations, financial condition and cash flows may be materially adversely affected, particularly if the pandemic persists for a significant period of time.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On March 27, 2020<i>, </i>the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law. The Act includes provisions relating to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. These provisions are not expected to have a material effect on the Company’s unaudited consolidated financial statements.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On April 29, 2020, the Company entered into a loan agreement with Preferred Bank under Paycheck Protection Program administered by SBA in the amount of $272,713. Under this loan program, the loan may be forgiven if utilized for specific purpose specified under the CARES Act and PPP guideline. The loan bears interest of 1.00% per annum and matures on April 29, 2022. The loan was forgiven on November 8, 2021.</p>
CY2020Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	272713	usd
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6915	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2513831	usd
CY2022Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	407090	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	76127	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	685332	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	5590000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	5590000	usd
CY2022Q2	us-gaap	Security Deposit SecurityDeposit	18316	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	18316	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1144415	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	736253	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14104587	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6420696	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1864663	usd
CY2022Q2	us-gaap	Goodwill Goodwill	26625946	usd
CY2021Q4	us-gaap	Goodwill Goodwill	6048034	usd
CY2022Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	500000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27871827	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3366179	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6915	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4184532	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8369068	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7894024	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3208176	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	846661	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3187	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24505648	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	649900	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	649900	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	649900	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	649900	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000000	usd
CY2021Q4	grbx	Debt Issuance Costs Gross Percent DebtIssuanceCostsGrossPercent	0.16	pure
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	16000000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q4	grbx	Debt Default Interest Rate DebtDefaultInterestRate	0.15	pure
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	5582164	usd
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	11102986	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	1780000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	3618222	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	18735000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-18673994	usd
CY2022Q2	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	61006	usd
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5000000	usd
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2413100	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2.07
CY2022Q2	us-gaap	Debt Instrument Convertible Terms Of Conversion Feature DebtInstrumentConvertibleTermsOfConversionFeature	If the Company’s common stock closing price remains under $5.50, the investor can convert up to another $25 million of the note at a conversion price that is the lower of (i) the then in effect conversion price and (ii) the greater of (x) the Note’s $1.67 floor price or (y) 98% of the market price on the conversion date
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	477430	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	230122	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.59
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	100802	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	460000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	31251	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.5
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	575499	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.06
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6865703	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	446295	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.37
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5324299	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	547834	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.8
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6535660	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	391562	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12417	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	70000.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9702	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.24
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	369443	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.47
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	387916	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	369443	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.47
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	387916	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	369443	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.47
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	387916	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	39413	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	39413	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	548039	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	508626	shares
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	221090	shares
CY2021Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	20455875	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5590000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	33333	shares
CY2022Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	533333	shares
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	186331	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	33333	shares
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	500000	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	198409	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	67685	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	357831	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	100789	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	464384	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	671630	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	462452	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	350422	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	248605	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	42463	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2239956	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	279012	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1960944	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	728076	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1232868	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Central Index Key EntityCentralIndexKey	0001419275

Files In Submission

Name	View Source	Status
0001185185-22-000938-index-headers.html	Edgar Link	pending
0001185185-22-000938-index.html	Edgar Link	pending
0001185185-22-000938.txt	Edgar Link	pending
0001185185-22-000938-xbrl.zip	Edgar Link	pending
ex_411637.htm	Edgar Link	pending
ex_411638.htm	Edgar Link	pending
ex_411639.htm	Edgar Link	pending
ex_411640.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grbx-20220630.xsd	Edgar Link	pending
greenbox20220630_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
grbx-20220630_cal.xml	Edgar Link	unprocessable
grbx-20220630_lab.xml	Edgar Link	unprocessable
grbx-20220630_pre.xml	Edgar Link	unprocessable
grbx-20220630_def.xml	Edgar Link	unprocessable
greenbox20220630_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RVYL
RYVYL Inc. Stock $rvyl

2022 Q3 Form 10-Q Financial Statement

#000118518522000938 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVYL RYVYL Inc. Stock $rvyl

2022 Q3 Form 10-Q Financial Statement

#000118518522000938 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RVYL
RYVYL Inc. Stock $rvyl